Tempus AI says 13 clinical research abstracts win ESMO 2026 presentation slots

Bitget2026/10/01 12:34

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Tempus AI disclosed 13 cancer research abstracts accepted for ESMO Congress 2026 in Madrid, with presentations scheduled for Oct. 23-27.
Results will be presented in the future, using real-world multimodal data to flag clinically meaningful differences in tumor biology, treatment response, outcomes.
Readouts span major solid tumors, including prostate cancer, breast cancer, non-small cell lung cancer, ovarian cancer.
Program supports precision-oncology biomarker work, patient stratification, clinical-trial design, reinforcing the company’s data and AI product strategy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261001487815) on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Tempus AI says 13 clinical research abstracts win ESMO 2026 presentation slots

You may also like

Crypto prices